ALS Drug Trial Fails to Slow Disease Progression
Featured

ALS Drug Trial Fails to Slow Disease Progression

Child Vaccines

Football Players’ ALS Risk Under Scrutiny
Child Vaccines
September 12, 2026

Football Players' ALS Risk Under Scrutiny

Football players face a fourfold higher risk of developing ALS, according to a 2021 study,...

Zap Highlights Key Health and Aged Care Updates
Child Vaccines
September 8, 2026

Zap Highlights Key Health and Aged Care Updates

Australia's latest health literacy push, aged‑care shortages and heated tobacco policy debates in this week’s...

Victorian Labor’s free dental clinics face scrutiny
Child Vaccines
August 31, 2026

Victorian Labor's free dental clinics face scrutiny

Free dental clinics in Victoria spark debate as Labor promises ten new sites, drawing praise...

Germ Control

Read our latest Germ Control articles.

Oveporexton Shows Symptom Improvement in Narcolepsy Type 1%
Germ Control September 15, 2026

Oveporexton Shows Symptom Improvement in Narcolepsy Type 1%

Oveporexton shows symptom improvement in narcolepsy type 1, improving wakefulness and quality of life.

Coalition tobacco policy sparks health fears
Germ Control September 4, 2026

Coalition tobacco policy sparks health fears

Coalition tobacco policy sparks health fears amid industry influence concerns, threatening public health.

Growth Charts

Gene therapy shows promise for seizure patients
Growth Charts

Gene therapy shows promise for seizure patients

September 10, 2026
How America fights back against populism
Growth Charts

How America fights back against populism

September 9, 2026
Right to bear witness under attack
Growth Charts

Right to bear witness under attack

August 28, 2026
Lunch Nutrition
Lunch Nutrition

Genetic testing aids epilepsy diagnosis in children

September 17, 2026
Lunch Nutrition

Eight New Muscular Dystrophy Therapies Show Promise

September 14, 2026
Lunch Nutrition

FDA fast-tracks first drug for MOGAD

September 11, 2026

All Posts

ALS Drug Trial Fails to Slow Disease Progression
Growth Charts

ALS Drug Trial Fails to Slow Disease Progression

Denali Therapeutics halted the SAR443820 trial after a phase 2 study failed to slow functional decline in adults with ALS,...

Genetic testing aids epilepsy diagnosis in children
Lunch Nutrition

Genetic testing aids epilepsy diagnosis in children

Genetic testing aids epilepsy diagnosis in children with seizures and developmental delays, offering new insights into disease origins.

Expert Discusses TDP-43 Role in ALS Research
Germ Control

Expert Discusses TDP-43 Role in ALS Research

Expert discusses TDP-43 role in ALS research, a protein present in 97% of ALS patients, to make ALS livable.

Oveporexton Shows Symptom Improvement in Narcolepsy Type 1%
Germ Control

Oveporexton Shows Symptom Improvement in Narcolepsy Type 1%

Oveporexton shows symptom improvement in narcolepsy type 1, improving wakefulness and quality of life.

Eight New Muscular Dystrophy Therapies Show Promise
Lunch Nutrition

Eight New Muscular Dystrophy Therapies Show Promise

Eight new muscular dystrophy therapies show promise in targeting disease mechanisms, moving beyond traditional care to advanced treatments for neuromuscular...

Football Players’ ALS Risk Under Scrutiny
Child Vaccines

Football Players’ ALS Risk Under Scrutiny

Football players face a fourfold higher risk of developing ALS, according to a 2021 study, sparking concern over long-term neurological...

FDA fast-tracks first drug for MOGAD
Lunch Nutrition

FDA fast-tracks first drug for MOGAD

The FDA fast-tracks satralizumab for MOGAD, a rare autoimmune disease. This decision could make it the first approved therapy for...

Gene therapy shows promise for seizure patients
Growth Charts

Gene therapy shows promise for seizure patients

Gene therapy shows promise for seizure patients with sustained reductions in seizure frequency and improved behavior.

How America fights back against populism
Growth Charts

How America fights back against populism

America’s fight against far-right populism reveals strategies to protect science, health policy, and democracy—key lessons for nations like Australia.

Zap Highlights Key Health and Aged Care Updates
Child Vaccines

Zap Highlights Key Health and Aged Care Updates

Australia's latest health literacy push, aged‑care shortages and heated tobacco policy debates in this week’s key health and aged care...

Show More →